Abstract
The use of intravenous (i.v.) antihypertensives in the treatment of cardiovascular-related hypertensive emergencies crosses distinct areas of clinical care and therapeutic applications. From first contact with emergency medical services (EMS) personnel, through the entire course of patient evaluation and care to medication considerations at the time of discharge, the applications for the i.v. antihypertensives are multiple and varied. This article describes the frequently encountered cardiovascular-related conditions found in their respective clinical settings and the utility of various antihypertensive treatment options.
Keywords: Hypertensive emergencies, intravenous antihypertensives, cardiovascular, acute coronary syndrome (ACS), perioperative hypertension, abdominal aortic aneurysm, catecholamine excess, deliberate hypotension
Current Vascular Pharmacology
Title: Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care
Volume: 7 Issue: 2
Author(s): Joseph Varon and Albert T. Cheung
Affiliation:
Keywords: Hypertensive emergencies, intravenous antihypertensives, cardiovascular, acute coronary syndrome (ACS), perioperative hypertension, abdominal aortic aneurysm, catecholamine excess, deliberate hypotension
Abstract: The use of intravenous (i.v.) antihypertensives in the treatment of cardiovascular-related hypertensive emergencies crosses distinct areas of clinical care and therapeutic applications. From first contact with emergency medical services (EMS) personnel, through the entire course of patient evaluation and care to medication considerations at the time of discharge, the applications for the i.v. antihypertensives are multiple and varied. This article describes the frequently encountered cardiovascular-related conditions found in their respective clinical settings and the utility of various antihypertensive treatment options.
Export Options
About this article
Cite this article as:
Varon Joseph and Cheung T. Albert, Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care, Current Vascular Pharmacology 2009; 7 (2) . https://dx.doi.org/10.2174/157016109787455590
DOI https://dx.doi.org/10.2174/157016109787455590 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
History and Therapeutic Use of MAO-A Inhibitors: A Historical Perspective of MAO-A Inhibitors As Antidepressant Drug
Current Topics in Medicinal Chemistry Recent Updates on the Systemic and Local Safety of Intranasal Steroids
Current Drug Metabolism Childhood Overweight and Obesity: Introduction into Epidemiology and Prevention Strategies
Current Nutrition & Food Science Detection of Secretion Retention in the Ventilated Patient
Current Respiratory Medicine Reviews The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Current Clinical Pharmacology Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Current Pharmaceutical Design The Role of Hypoxia in Endometrial Cancer
Current Pharmaceutical Biotechnology Survey of Recent Literature Related to the Biologically Active 4(3H)-Quinazolinones Containing Fused Heterocycles
Current Medicinal Chemistry Preparation and Evaluation of Quercetin-Loaded MPEG-PLA Nanoparticles
Current Nanoscience Are Monocyte, %M and WBC Biomarkers in the First Trimester Screening Test?
New Emirates Medical Journal Potential Role of Hydrogen Sulfide in the Pathogenesis of Vascular Dysfunction in Septic Shock
Current Vascular Pharmacology The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets eNOS Uncoupling in Cardiovascular Diseases - the Role of Oxidative Stress and Inflammation
Current Pharmaceutical Design Endothelial Dysfunction under the Scope of Arterial Hypertension, Coronary Heart Disease, and Diabetes Mellitus using the Angioscan
Cardiovascular & Hematological Agents in Medicinal Chemistry Apolipoprotein E Gene Revisited: Contribution of Rare Variants to Alzheimer’s Disease Susceptibility in Southern Chinese
Current Alzheimer Research New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus
Current Medicinal Chemistry Patent Foramen Ovale in Cerebral Infarction
Current Cardiology Reviews Current Therapeutic Alternatives and New Perspectives in Glioblastoma Multiforme
Current Medicinal Chemistry Vitamin D in Atherosclerosis, Vascular Disease, and Endothelial Function
Current Drug Targets Prevalence of Cognitive Impairment and Dementia in Malays – Epidemiology of Dementia in Singapore Study
Current Alzheimer Research